about
Differential regulation of cadherins by dexamethasone in human osteoblastic cellsMolecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathwayGermline TP53 variants and susceptibility to osteosarcoma.Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1.Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype.ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced MetastasisThe Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models.Bone metastases in lung cancer. Potential novel approaches to therapy.The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity.miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization.RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive mannerA gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer.Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance.ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models.Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma.CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer.An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation.EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growthInhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.Proliferation, differentiation and apoptosis in connexin43-null osteoblasts.Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival.Radiation effects on antitumor immune responses: current perspectives and challenges.A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.Cyclic stretch enhances gap junctional communication between osteoblastic cells.Gap junctional communication modulates gene transcription by altering the recruitment of Sp1 and Sp3 to connexin-response elements in osteoblast promoters.Microvesicles: Isolation, Characterization for In Vitro and In Vivo Procedures.New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.Profiling of Chemonaive Osteosarcoma and Paired-Normal Cells Identifies EBF2 as a Mediator of Osteoprotegerin Inhibition to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced ApoptosisLas metástasis óseas del cáncerChanges in skeletal metabolism after the administration of demineralized bone proteins and fluorideRegulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cellsRegulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasoneAe2(a,b)-deficient mice exhibit osteopetrosis of long bones but not of calvaria
P50
Q28141575-EAEECCCE-FA28-4EE3-890C-82254D776900Q36088646-1B888A65-8A7A-4893-ADAB-543E7A1ADB08Q36294747-583F57C1-F8DF-4C51-AFB2-24712BA2D09BQ36398042-0C793398-9539-496A-AD97-F27DF1AE6935Q36413760-D9F58D07-6354-47BE-8250-DC34F7ED2F71Q36963424-0D9E2DB1-F41D-4B9D-8C07-8B2E9603A042Q37648939-A273C0E4-CB53-4E3E-BDE7-0E5F9EF703A0Q38541387-891A23C2-B422-42E3-81F4-6A7BC8E4CD8DQ39003657-64ABBB99-D73C-49F1-B8EB-A5C861060F39Q39018734-6B082B6F-2A1B-402B-B993-1526EFC92E66Q39045155-A4AC7541-0BB9-47FB-B8A6-1797D9FD740EQ39069356-0BB43492-F8CC-4F02-B635-8AC5A413C805Q39070928-18D1F09A-F2BF-4D67-98F0-D6EFEBDBE8ECQ39173570-B811C327-31D0-4B2E-B691-B4D1876B972FQ39499534-92DBA00A-F7C2-4B01-952C-8F3B964B643AQ39522909-BA2E02B8-6FC5-4CEF-9667-176CD9BF8547Q39594126-3E3BD7C6-671D-4140-B8DA-AB0D12F71694Q39706014-7274CA88-3702-48C2-A9ED-B360194CBB12Q40324354-43B3B516-FD14-450A-AABB-B525B3E92FD0Q41049156-21C51A6E-C063-4EFA-98BC-DFF134349142Q42329454-5ACD8643-31BF-48B7-831C-58DE1BD87509Q42500078-647145E9-82CC-4E33-BF70-091CFAC21BD1Q44027846-5C2C28A9-6B25-4993-A3AA-8E292B39B5B4Q46403981-10F18BE7-0E7C-4C94-9ED8-443843FAFBCBQ47703452-3D190857-9812-46DB-A9AB-7384E456300FQ50213566-127DCB8E-B199-4960-AC74-535DCEB5A626Q52529451-932193D7-795D-41AA-959B-CA2F7B53A0E5Q52550218-4F2923F6-D523-4191-A31B-DDA7E38EB10BQ52904885-57C4D327-95B7-4F81-9D53-961AAF1F54F1Q53243017-460C69A2-AE9E-48BF-BCCC-1D8BF81BB9B6Q58051500-DEBC3000-A6B0-4E28-9323-482EBECA8ECFQ58051521-2FA2D7E1-B943-4EE6-A291-F03348016B75Q71014580-DF60DB4C-9902-4011-B123-1793DEDF46D9Q73960566-B61468F5-B65E-4A4D-9FF2-3DB152303316Q77608195-0844F1FC-67B6-4C1F-9E2F-490E64ECB535Q84141389-99465034-F33B-45B5-908D-C16090BB41CA
P50
description
researcher
@en
wetenschapper
@nl
name
Fernando Lecanda
@en
Lecanda F
@nl
type
label
Fernando Lecanda
@en
Lecanda F
@nl
altLabel
Lecanda F
@en
prefLabel
Fernando Lecanda
@en
Lecanda F
@nl
P106
P31
P496
0000-0002-7289-2293